1. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, Atlanta (GA): Centers for Disease Control and Prevention (US). The health consequences of smoking—50 years of progress: A report of the Surgeon General. 2014.
2. Benowitz NL. Nicotine addiction. N. Engl J Med. 2010;362:2295–303.
3. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, et al. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Disposition. 1996;24:1212–7.
4. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, et al. Characterization of CYP2A6 involved in 3’-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Therapeutics. 1996;277:1010–5.
5. Benowitz NL, St Helen G, Dempsey DA, Jacob P III, Tyndale RF. Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: Impact of CYP2A6 genetic variation and enzymatic activity. Pharmacogenet Genomics. 2016;26:340–50.